Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period

被引:12
作者
Fujita, Kohei [1 ,2 ]
Kada, Shinpei [2 ,3 ]
Kanai, Osamu [1 ,2 ]
Hata, Hiroaki [2 ,4 ]
Odagaki, Takao [2 ,5 ]
Satoh-Asahara, Noriko [6 ,7 ]
Tagami, Tetsuya [6 ,7 ]
Yasoda, Akihiro [6 ,7 ]
机构
[1] Natl Hosp Org Kyoto Med Ctr, Ctr Resp Dis, Div Resp Med, Kyoto, Japan
[2] Natl Hosp Org Kyoto Med Ctr, Dept Infect Dis, Kyoto, Japan
[3] Natl Hosp Org Kyoto Med Ctr, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan
[4] Natl Hosp Org Kyoto Med Ctr, Dept Surg, Kyoto, Japan
[5] Natl Hosp Org Kyoto Med Ctr, Dept Gen Med, Kyoto, Japan
[6] Natl Hosp Org Kyoto Med Ctr, Dept Endocrinol & Metab, Kyoto, Japan
[7] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Endocrinol Metab & Hypertens Res, Kyoto, Japan
基金
日本学术振兴会;
关键词
COVID-19; seroprevalence; SARS-CoV-2; ELISA; antibody;
D O I
10.3389/fpubh.2020.595348
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The coronavirus disease-2019 (COVID-19) pandemic is associated with a heavy burden on the mental and physical health of patients, regional healthcare resources, and global economic activity. While understanding of the incidence and case-fatality rates has increased, there are limited data concerning seroprevalence of antibodies against the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in healthcare workers during the pre-pandemic period. This study aimed to quantitatively evaluate seroprevalence of SARS-CoV-2 antibodies in healthcare workers in the southern part of Kyoto city, Japan. Methods: We prospectively recruited healthcare workers from a single hospital between April 10 and April 20, 2020. We collected serum samples from these participants and quantitatively evaluated SARS-CoV-2 IgG antibody levels using enzyme-linked immunosorbent assays. Results: Five (5.4%), 15 (16.3%), and 72 (78.3%) participants showed positive, borderline, and negative serum SARS-CoV-2 IgG antibody status, respectively. We found the mean titer associated with each antibody status (overall, positive, borderline, and negative) was clearly differentiated. Participants working at the otolaryngology department and/or with a history of seasonal common cold symptoms had a significantly higher SARS-CoV-2 IgG antibody titer (p = 0.046, p = 0.046, respectively). Conclusions: Five (5.4%) and 15 (16.3%) participants tested positive and borderline, respectively, for SARS-CoV-2 IgG antibody during the COVID-19 pre-pandemic period. These rates were higher than expected, based on government situation reports. These findings suggest that COVID-19 had already spread within the southern part of Kyoto city at the early stage of the pandemic.
引用
收藏
页数:7
相关论文
共 17 条
[1]  
Akiyama Y, 2020, medRxiv, DOI [10.1101/2020.04.06.20055251, 10.1101/2020.04.06.20055251, DOI 10.1101/2020.04.06.20055251]
[2]  
Bendavid E., 2020, COVID 19 ANTIBODY SE, DOI 10.1101/2020.04.14.20062463
[3]   Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].
Chen, Nanshan ;
Zhou, Min ;
Dong, Xuan ;
Qu, Jieming ;
Gong, Fengyun ;
Han, Yang ;
Qiu, Yang ;
Wang, Jingli ;
Liu, Ying ;
Wei, Yuan ;
Xia, Jia'an ;
Yu, Ting ;
Zhang, Xinxin ;
Zhang, Li .
LANCET, 2020, 395 (10223) :507-513
[4]  
Doi A, 2020, MEDRXIV, DOI [10.1101/2020.04.26.20079822, DOI 10.1101/2020.04.26.20079822]
[5]  
Fujita K, 2020, QUANTITATIVE SARS CO, DOI [10.1101/2020.05.12.20098962, DOI 10.1101/2020.05.12.20098962]
[6]   Clinical Characteristics of Coronavirus Disease 2019 in China [J].
Guan, W. ;
Ni, Z. ;
Hu, Yu ;
Liang, W. ;
Ou, C. ;
He, J. ;
Liu, L. ;
Shan, H. ;
Lei, C. ;
Hui, D. S. C. ;
Du, B. ;
Li, L. ;
Zeng, G. ;
Yuen, K. -Y. ;
Chen, R. ;
Tang, C. ;
Wang, T. ;
Chen, P. ;
Xiang, J. ;
Li, S. ;
Wang, Jin-lin ;
Liang, Z. ;
Peng, Y. ;
Wei, L. ;
Liu, Y. ;
Hu, Ya-hua ;
Peng, P. ;
Wang, Jian-ming ;
Liu, J. ;
Chen, Z. ;
Li, G. ;
Zheng, Z. ;
Qiu, S. ;
Luo, J. ;
Ye, C. ;
Zhu, S. ;
Zhong, N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) :1708-1720
[7]  
Kamikubo Y, 2020, CAMBRIDGE OPEN ENGAG, DOI [10.33774/coe-2020-fsnb3-v2, DOI 10.33774/COE-2020-FSNB3-V2]
[8]  
Kyoto City Official Website, NOV COR INF TREND LA
[9]   Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection [J].
Lin, Qingqing ;
Zhu, Li ;
Ni, Zuowei ;
Meng, Haitao ;
You, Liangshun .
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (05) :821-822
[10]  
Long QX, 2020, NAT MED, V26, P845, DOI [10.1093/cid/ciaa344, 10.1038/s41591-020-0897-1]